More on AMRN
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Revenues | 32.73M |
| Operating Expenses: | |
| Research and development | 13.49M |
| Marketing, general and administrative | 26.06M |
| Total operating expenses | 39.55M |
| Operating loss | -15.27M |
| Loss on change in fair value of derivative liability | 3.61M |
| Interest (income) expense, net | -5.05M |
| Other (income) expense, net | |
| Loss from operations before taxes | |
| Provision for income taxes | 1.02M |
| Net and comprehensive loss | -15.77M |
| Loss per share: | |
| Basic and diluted | |
| Weighted average shares: | |
| Basic and diluted | |
Entities mentioned with AMRN
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Jefferies & Co | View Related Stories »
- Definitive Agreement | View Related Stories »
- JPMorgan | View Related Stories »
- AdCom | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- Options | View Related Stories »
- Show More...
